Contact Us

Please fill the form below to ask information.

We're Here For You 7/24




State-of-the-art devices are used for diagnosis and treatment of all diseases in Okan University. Using the cutting-edge medical devices for the first time in Turkey, Okan University Hospital pioneers the sector.

State-of-the-art devices offer diagnostic and therapeutic options in different medical departments of Okan University Hospital.


Don’t Be Afraid of Cancer Thanks to Advanced Technology!

Elekta Versa HD is characterized with maximum number of multi-leaf collimator (namely, 160) in this field and thus, target volume is more precisely modeled and doses received by healthy organs are minimized. Since it has the maximum number of MLC, duration of treatment is shortened relative to other devices.

Thanks to the collimator structure that has five times lower leaf leakage transmission, influence of radiation on intact organs and risks of secondary cancer are minimized. This is particularly advantageous for PEDIATRIC TUMORS.

Now, Personalized or Tailored Treatments Are Available Similar to Fashion Designers!

Since we could not clearly see the target region in the past, we needed to use very large areas; accordingly, radiotherapy was delivered to a larger area in order to treat the tumor or in other words, all patients required to wear XL shields. Since conebeam CT feature of the Elekta Versa HD device clearly visualizes the region that we deliver radiation at daily intervals, we can, now, offer personalized, tailored or “haute couture” treatment for all patients. This treatment, also known as IGRT, enables delivering high doses to the tumor, while the intact tissue is provided with maximum protection.

Non-operative Treatment with Radiotherapy

For patients with early stage lung cancers who cannot be operated due to a reason whatsoever, the tumor can be treated with a success rate close to that of surgery by delivering very high dose of radiation only to the tumor, colloquially known as “pinpoint shooting”, using radio-surgery method with Electa Versa HD for 1 to 3 days.

Accordingly, patients with lung cancer, who were deemed inoperable or incurable in the past, are no more desperate; outcomes are very close to that of surgery cases.

Now, Radiotherapy Takes Shorter Time

As you already know, radiotherapy lasts for 5 to 8 weeks, but Elekta HD Versa and similar devices with superior technology offers safe therapies that last 3 or 5 days. In selected patients with prostate cancer, a 5-day treatment achieves all outcomes of a 8-week treatment and accordingly, patient needs shorter stay in hospital before daily routines are engaged.

The high-dose radiotherapy delivered in one day manages the pain rapidly in cerebral (brain) and spinal (vertebra) metastases, while surrounding tissue and spinal cord are not harmed; in addition, healthy brain tissues are conserved.

Technology Means Acceleration

Elekta HD Versa and similar device shorten stereotactic and IMRT treatments by 2 to 3 folds relative to other devices and thus, patients with pain are safely treated without facing problems caused by staying immobile in the device for long times.

Radio-surgery (Operative Treatment with Radiation)

It is a superior device that can perform linear accelerator-based radiosurgery; moreover, highly precise treatment is offered to each patient with indication of radiotherapy. Since 6FFF and 10FFF photon energies enable filter-free treatment, dose velocity is increased up to 4 folds relative to filter treatments. Thus, even very complicated radiosurgeries take 5 to 20 minutes to complete.


This diagnostic device that is used for molecular imaging visualizes many organs, including but not limited to heart, kidney and bones. GE Discovery NM360 Spect device with double detectors complete imaging studies very quickly.


Creating and processing cross-sectional images of the body part visualized, the device is very useful in identifying cancers in liver, pancreas, adrenal glands, lungs and bones and to collect information about them.


Angiography implies visualizing all vessels by injecting contrast agent into lumen of the vessel and novel devices produces more clear images using far lower radiation doses. Advanced technology angiography devices were first used in Okan University Hospital in Turkey.


Representing the high-end diagnostic technology in the field of oncology, PET/CT is an imaging device that combines computed tomography and positron emission tomography. It may not only differentiate malignant tumors from benign neoplasms, it may also offer important information on the spread of tumor in the body. The PET/CT device installed in our hospital is the first 4-Ring Discovery IQ device in Turkey.


Considering all imaging and diagnostic methods, it can identify breast cancer at earliest stage. The mammography device installed in our hospital produces three-dimensional and high-quality images based on Contrast Spectral (CESM) feature.


The MRI device with the strongest infrastructure in technical terms posses the silent MRI technology for brain scans and it is strengthened with superior applications. No radiation beam is used for this technique, and MRI is especially superior in imaging the soft tissues. Many cancerous foci can be identified that are missed by other methods.


The Stealthstation S7 Navigation System equipped in Neusrosurgery Operating Theatre of Okan University Hospital is a high-tech device that intraoperatively guides the surgeon using previously scanned CT and MRI images for neurosurgery operations.

The Navigation System can be used for Cerebrovascular surgeries, tumor resection, biopsy and the transnasal operations as well as pediatric neurosurgery cases and the operations that involve the pituitary gland and the skull base or are carried out to treat hydrocephalus in the cranial surgery.

The system ensures that the locations of the navigation probes or other surgical instruments in an certain anatomic structure is known with a high geometric accuracy.

The location of the tumor is determined on the real anatomy before a craniotomy (removal of a cranial bone).

Thus, the surgeon determines the best route to Access the tumor and the smallest incision and drilling on the skull. It guides the surgeon to locate the tumor while advancing in the brain tissue after the craniotomy.

The surgeon is provided a visual guide to follow the shortest route that also ensures the accurate angle and the minimal tissue damage.